Up And Down The Ladder… Job Changes
1 CommentBy Ed Silverman // January 8th, 2010 // 8:12 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Dan Schultz, a former director of the FDA’s Center for Devices and Radiological Health, has joined Greenleaf Health, a consulting firm, as senior vice president, medical devices and combo products. He’s based in Washington, where former FDA commish Andy von Eschenbach is the firm’s senior advisor.
Clavis Pharma hired Olav Hellebo as ceo;
Sun Pharma hired S. Kalyanasundaram as an exec;
MacroGenics hired Anastasia Daifotis as sr vp clinical development;
Inovio Biomedical named Mark Bagarazzi as chief medical officer;
Biogen added Carol Dorsa to its board;
Genzyme hired Ron Branning as sr vp of global product quality;
CVS Caremark hired Per G.H. Lofberg as president of its PBM business;
Prolong Pharmaceuticals hired Richard Prince as vp, quality;
Cempra Pharma hired Don Olsen as exec vp of business development;
Cephalon says Robert Roche resigned as exec vp ww pharma operations;
Coventry Health Care hired Matt Eyles as vp, public affairs & policy;
Sanofi-Aventis hired Hans Regenauer as group vp, consumer health, Europe;
Canadian Institutes of Health Research named Rob Peterson as exec director, drug safety.
Ladder shot thx to Robert CB on Flickr Creative Commons
Ex-FDAer
Schultz and Von Eschenbach, birds of a feather flock together.